Dr. Luciano Costa, MD
Claim this profileUniversity of Alabama at Birmingham
Studies Multiple Myeloma
Studies Minimal Residual Disease
7 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Luciano Costa, MD is currently running
BMS-986453
for Multiple Myeloma
The purpose of this study is to assess BMS-986453 in participants with relapsed and/or refractory multiple myeloma (RRMM).
Recruiting1 award Phase 15 criteria
DaraVRD
for Multiple Myeloma
This trial uses a high-tech test to check for tiny amounts of leftover cancer cells in patients with newly diagnosed multiple myeloma. If no cancer cells are found, doctors might delay a major treatment called stem cell transplant. This approach aims to avoid the severe side effects of the transplant if it's not needed.
Recruiting3 awards Phase 29 criteria
More about Luciano Costa, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Luciano Costa, MD has experience with
- Daratumumab
- Dexamethasone
- Carfilzomib
- Iberdomide
- CB-011
- BMS-986158
Breakdown of trials Luciano Costa, MD has run
Multiple Myeloma
Minimal Residual Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luciano Costa, MD specialize in?
Luciano Costa, MD focuses on Multiple Myeloma and Minimal Residual Disease. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are undergoing treatment.
Is Luciano Costa, MD currently recruiting for clinical trials?
Yes, Luciano Costa, MD is currently recruiting for 6 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Luciano Costa, MD has studied deeply?
Yes, Luciano Costa, MD has studied treatments such as Daratumumab, Dexamethasone, Carfilzomib.
What is the best way to schedule an appointment with Luciano Costa, MD?
Apply for one of the trials that Luciano Costa, MD is conducting.
What is the office address of Luciano Costa, MD?
The office of Luciano Costa, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.